Market Montage
Stock Market, Economics, Equity Analysis
Mar26
The most likely answer to the above question if you ask the general populace is "the American citizen." Unfortunately, it is not quite that simple. In fact, one can make a wonderful argument that such actions, gaining in popularity among a certain political set, would be neutral to "the American citizen." One group benefits, and another one would pay for it – there is no net winner from moving obligations from one hand to another. Someone is owed that money, and with Fannie, Freddie, et al being run as large subsidization schemes guaranteed by the U.S. taxpayer – that is who loses. That said, per this excellent story by the NYT's Gretchen Morgenson, ,there would be one clear winner – our oligarchy of mega banks. Which makes me wonder why this proposal has not been approved long ago? Oh yes, it is not something Congres can be paid off to do. …
Mar26
Barron's was out this past weekend with a negative article on Alexion Pharmaceuticals (ALXN), stating a lot of things that are already known – namely that the current situation is this is a "one drug" story. [Feb 12, 2012: Alexion Pharmaceuticals - One Drug is Enough When it Costs this Much] But of course they have a very large megaphone. Alexion was one of the few stocks in my watch list to actually open down today.
As with any high growth, high beta stock – eventually the super growth era ends, and "valuation once more matters". When it does, it's usually a dark and ugly point for the stock as you lose the momentum growth investors and the "value" investors won't be touching said stock until a much lower point. Barron's seems to be making a pre-emptive strike on ALXN in this regard.
Mar26
The last week of the month has already gotten off to a roaring start in futures as Bernanke is out this morning with a speech saying the labor market remains poor, which the market is translating to more easing. I am unclear why the market ever has gone off the more easing bandwagon, but they seem to be reassured today than Ben will continue full steam ahead and of course markets love easy money. …
Mar23
This is one of the few days of the year the NASDAQ, and especially QQQ ETF, is not leading the charge. Apple (AAPL) is actually down while the S&P 500 and DJIA are the stronger indexes; in fact quite a few leading technology names are in the red. Meanwhile, the most beaten of the "slowdown in China" names are rebounding a bit along with the energy complex which has had a rough week. The S&P 500 is making an attempt to recapture the quickly rising 10 day moving average at 1397.70… the pullback this morning did not go as far as to touch the 20 day down at 1381-ish. That is the level from which this leg of the breakout started, so its an important level to hold for sustained movement. …
Mar23
Ummm… wow. In case you have not been following the saga of this VIX related product, it's been an interesting few days. After yesterday's plunge of nearly 30% (on a day VIX itself rose), the VelocityShares Daily 2x VIX Short-Term ETN (TVIX) opened today down another 20% or so. This is a pretty shameful reflection on the ETF market in my view; and it's not the first time we've seen such a dislocation in the ETF sphere the past 3-4 years. …
Sidebar
Subscribe
Explore the Fund Mark Manages
